(19)
(11) EP 2 802 662 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.02.2019 Bulletin 2019/08

(45) Mention of the grant of the patent:
26.12.2018 Bulletin 2018/52

(21) Application number: 13700169.9

(22) Date of filing: 10.01.2013
(51) International Patent Classification (IPC): 
C12N 15/867(2006.01)
C07K 16/24(2006.01)
C12N 5/0735(2010.01)
C07K 7/16(2006.01)
 C07K 14/12(2006.01)
C07K 16/28(2006.01)
C12N 5/0797(2010.01)
C12N 5/00(2006.01)
(86) International application number:
PCT/EP2013/050426
(87) International publication number:
WO 2013/104728 (18.07.2013 Gazette 2013/29)

(54)

USE OF PSEUDOTYPED LENTIVIRAL PARTICLES FOR IN VITRO TARGETED TRANSDUCTION OF UNDIFFERENTIATED PLURIPOTENT HUMAN EMBRYONIC STEM CELLS AND INDUCED PLURIPOTENT STEM CELLS

VERWENDUNG PSEUDOTYPISIERTER LENTIVIRUSPARTIKEL ZUR ZIELGERICHTETEN IN-VITRO-TRANSDUKTION VON UNDIFFERENZIERTEN PLURIPOTENTEN MENSCHLICHEN EMBRYOSTAMMZELLEN UND INDUZIERTEN PLURIPOTENTEN STAMMZELLEN

UTILISATION DE PARTICULES DE LENTIVIRUS PSEUDOTYPÉES POUR LA TRANSDUCTION CIBLÉE IN VITRO DE CELLULES SOUCHES EMBRYONNAIRES HUMAINES PLURIPOTENTES INDIFFÉRENCIÉES ET CELLULES SOUCHES PLURIPOTENTES INDUITES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.01.2012 EP 12000142

(43) Date of publication of application:
19.11.2014 Bulletin 2014/47

(73) Proprietor: Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe
63225 Langen (DE)

(72) Inventors:
  • SCHNEIDER, Irene
    63456 Hanau (DE)
  • BUCHHOLZ, Christian
    60594 Frankfurt (DE)
  • SCHUMANN, Gerald
    63225 Langen (DE)
  • JUNG-KLAWITTER, Sabine
    67433 Neustadt/Weinstrasse (DE)

(74) Representative: Grund, Martin 
Grund Intellectual Property Group Patentanwalt und Solicitor PartG mbB Postfach 44 05 16
80754 München
80754 München (DE)


(56) References cited: : 
WO-A1-03/056019
 WO-A2-2008/037458
   
  • S FUNKE ET AL: "Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity", GENE THERAPY, vol. 16, no. 5, 1 May 2009 (2009-05-01), pages 700-705, XP055033658, ISSN: 0969-7128, DOI: 10.1038/gt.2009.11
  • FUNKE SABRINA ET AL: "HIV-1 Derived Vectors Pseudotyped with Measles Virus Glycoproteins: Targeting and Transduction of Resting Cells", MOLECULAR THERAPY, vol. 17, no. Suppl. 1, May 2009 (2009-05), pages S1-S2, XP008153816, & 12TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE THERAPY; SAN DIEGO, CA, USA; MAY 27 -30, 2009 ISSN: 1525-0016
  • BRIGITTE ANLIKER ET AL: "Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors", NATURE METHODS, vol. 7, no. 11, 1 November 2010 (2010-11-01), pages 929-935, XP055033622, ISSN: 1548-7091, DOI: 10.1038/nmeth.1514
  • JANG JUNG-EUN ET AL: "Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors.", STEM CELLS AND DEVELOPMENT FEB 2006 LNKD- PUBMED:16522168, vol. 15, no. 1, February 2006 (2006-02), pages 109-117, XP008153783, ISSN: 1547-3287
  • SUZANNE KADEREIT ET AL: "In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages", SEMINARS IN IMMUNOPATHOLOGY, SPRINGER, BERLIN, DE, vol. 33, no. 6, 5 April 2011 (2011-04-05), pages 551-562, XP019969947, ISSN: 1863-2300, DOI: 10.1007/S00281-011-0265-9
  • MATEIZEL I ET AL: "Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically", HUMAN REPRODUCTION (OXFORD), vol. 24, no. 10, October 2009 (2009-10), pages 2477-2489 URL, XP008153800,
  • LAGARKOVA MARIA A ET AL: "CD 30 is a marker of undifferentiated human embryonic stem cells rather than a biomarker of transformed hESCs", CELL CYCLE, LANDES BIOSCIENCE, US, vol. 7, no. 22, 15 November 2008 (2008-11-15), pages 3610-3612, XP009152240, ISSN: 1551-4005, DOI: 10.4161/CC.7.22.6981
  • T.-Y. LU ET AL: "Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 285, no. 12, 19 March 2010 (2010-03-19), pages 8719-8732, XP055033615, ISSN: 0021-9258, DOI: 10.1074/jbc.M109.077081
  • C. GRANDELA ET AL: "hESC Adaptation, Selection and Stability", STEM CELL REVIEWS AND REPORTS, vol. 3, no. 3, 20 September 2007 (2007-09-20), pages 183-191, XP055033613, ISSN: 1550-8943, DOI: 10.1007/s12015-007-0008-4
  • DANIELLA HERSZFELD ET AL: "CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells", NATURE BIOTECHNOLOGY, vol. 24, no. 3, 1 March 2006 (2006-03-01), pages 351-357, XP055033614, ISSN: 1087-0156, DOI: 10.1038/nbt1197
  • BUCHHOLZ C J ET AL: "Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer?", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 27, no. 5, 1 May 2009 (2009-05-01), pages 259-265, XP026018665, ISSN: 0167-7799, DOI: 10.1016/J.TIBTECH.2009.02.002 [retrieved on 2009-03-25]
  • Anonymous: "Protocol for Transduction of Human Embryonic Stem Cells (hESCs) using Lentiviral Vectors | Sigma-Aldrich", , 3 November 2008 (2008-11-03), XP55234853, Retrieved from the Internet: URL:http://www.sigmaaldrich.com/technical- documents/articles/biofiles/protocol-for-t ransduction.html [retrieved on 2015-12-09]
  • Gropp, M. & Reubinoff, B.: "Lentiviral vector-mediated gene delivery into human embryonic stem cells" In: Klimanskaya, I; Lanza, R: "Methods in Enzymology", 2006, METHODS IN ENZYMOLOGY ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA SERIES : METHODS IN ENZYMOLOGY (ISSN 0076-6879(PRINT)), PAGE(S) 64-81, XP008178403, ISSN: null ISBN: 0-12-373651-X pages 64-81, * abstract * * page 67 - page 80; figures 1, 2 *
  • THORSTEN FRIEDEL ET AL: "CD30 Receptor-Targeted Lentiviral Vectors for Human Induced Pluripotent Stem Cell-Specific Gene Modification", STEM CELLS AND DEVELOPMENT, vol. 25, no. 9, 1 May 2016 (2016-05-01), pages 729-739, XP055354725, NL ISSN: 1547-3287, DOI: 10.1089/scd.2015.0386
  • Dai-Tze Wu ET AL: "Antibody-Directed Lentiviral Gene Transduction for Live-Cell Monitoring and Selection of Human iPS and hES Cells", PLoS ONE, vol. 7, no. 4, 20 April 2012 (2012-04-20), page e34778, XP055355097, DOI: 10.1371/journal.pone.0034778
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).